American ginseng

What human studies say about american ginseng

• Cancer-related fatigue · Randomized controlled trial · 2013
  The change in the general fatigue score was not significantly different from placebo at 4 weeks (P = .07). At 8 weeks, the ginseng group improved more than placebo (20 vs 10.3, P = .003). Toxicities did not differ between arms. Limitation: The primary endpoint at 4 weeks was not statistically significant, and fatigue was self-reported. Benefit appeared greater in people still receiving cancer treatment. PubMed 23853057
• Cognitive performance · Randomized crossover trial · 2020
  American ginseng was associated with reduced prefrontal brain-signal latency during working-memory retrieval compared with placebo. There were no significant treatment effects on continuous performance or on behavioural performance in either task. Limitation: This was a single acute dose with preliminary brain-signal findings. There was no behavioural improvement, and the sample size is not stated in the abstract. PubMed 32896022

Most studies used extracts or doses that differ from home cooking. Full details in the Nourilo Research Library.

Safety: Has been shown to weaken the effect of warfarin and may lower blood sugar. Talk to your doctor first if you take blood thinners or diabetes medicines. Source: Memorial Sloan Kettering — American Ginseng